Evidence map›Paper›PMID 40793774›Full record

ArticlemBio2025

ABCF protein-mediated resistance shapes bacterial responses to antibiotics based on their type and concentration.

Markéta Koběrská, Ludmila Veselá, Michaela Novotná, Durga Mahor, Aninda Mazumdar, Nikola Pinďáková, Pamela Omena Petravicius, Julie Pokorná, Zdeněk Kameník, Gabriela Balíková Novotná

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Markéta Koběrská *Institute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0000-0002-9787-4227
Ludmila Veselá *Institute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0009-0008-8096-346X
Michaela NovotnáInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0000-0001-5068-8454
Durga MahorInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0000-0002-7021-7999
Aninda MazumdarInstitute of Microbiology of the CAS, Prague, Czech Republic.ORCID 0000-0002-4985-7115
Nikola PinďákováInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.
Pamela Omena PetraviciusInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0000-0002-4693-5456
Julie PokornáInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0009-0004-4878-1851
Zdeněk KameníkInstitute of Microbiology of the CAS, Prague, Czech Republic.ORCID 0000-0002-5363-0597
Gabriela Balíková NovotnáInstitute of Microbiology of the CAS; BIOCEV, Vestec, Czech Republic.ORCID 0000-0002-5464-4763

Funding

Grantová Agentura, Univerzita Karlova 134324Grantová Agentura, Univerzita Karlova 1767418Ministerstvo Školství, Mládeže a Tělovýchovy CZ.02.01.01/00/22_008/0004597,LX22NPO5103Ministerstvo Školství, Mládeže a Tělovýchovy CZ.02.01.01/00/22_010/0006118
6 · The paper itself

Abstract

ABCF-ATPases are increasingly recognized as translation factors that rescue stalled ribosomes when they encounter difficult mRNA templates or are stalled by antibiotics. The latter defines antibiotic resistance ABCF (ARE ABCF) proteins, known for their role in antibiotic resistance. However, in this study, we reveal a broader role of ARE ABCFs in antibiotic-responsive regulation. Using genetic, OMICs, and biochemical approaches, we showed that ARE ABCF proteins TiaA and Are5sc in IMPORTANCE: Bacteria adapt to diverse stimuli mainly through transcriptional changes that regulate adaptive protein factors. Here, we show that responses to protein synthesis-inhibiting antibiotics are fine-tuned by antibiotic resistance ABCF proteins at the translational level, enabling bacteria to differentiate between antibiotic classes and concentrations for a tailored response. Additionally, we have demonstrated that these proteins can specialize in conferring high-level resistance to specific antibiotics. Given their prevalence in pathogenic bacteria, antibiotic resistance ABCF (ARE ABCF) proteins may play a crucial role in resistance development, particularly against new antibiotics targeting the ribosomal catalytic center, presenting a significant challenge for antimicrobial therapy.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialStreptomyces coelicolorDiterpenesGene Expression Regulation, BacterialLincosamidesMicrobial Sensitivity TestsPleuromutilinsPolycyclic CompoundsProtein BiosynthesisAnti-Bacterial AgentsBacterial ProteinsDiterpenesLincosamidesPleuromutilinsPolycyclic CompoundsABCF proteinsantibiotic resistanceStreptomycesstress adaptationstress responsetranslational control

Identifiers

PMID40793774
PMCPMC12421871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.